Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Codexis Inc (CDXS)

Codexis Inc (CDXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 191,930
  • Shares Outstanding, K 70,304
  • Annual Sales, $ 70,140 K
  • Annual Income, $ -76,240 K
  • 60-Month Beta 2.01
  • Price/Sales 2.70
  • Price/Cash Flow N/A
  • Price/Book 2.31
Trade CDXS with:

Options Overview Details

View History
  • Implied Volatility 114.74% ( +48.85%)
  • Historical Volatility 50.23%
  • IV Percentile 67%
  • IV Rank 16.01%
  • IV High 659.81% on 10/17/23
  • IV Low 10.87% on 06/21/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 26
  • Volume Avg (30-Day) 27
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 2,545
  • Open Int (30-Day) 2,427

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.17
  • Number of Estimates 3
  • High Estimate -0.15
  • Low Estimate -0.18
  • Prior Year -0.34
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.57 +7.39%
on 04/16/24
3.72 -25.78%
on 03/28/24
-0.57 (-17.12%)
since 03/15/24
3-Month
2.53 +9.09%
on 02/06/24
4.91 -43.79%
on 02/29/24
+0.08 (+2.99%)
since 01/17/24
52-Week
1.45 +90.34%
on 09/26/23
4.91 -43.79%
on 02/29/24
-1.58 (-36.41%)
since 04/17/23

Most Recent Stories

More News
Codexis: Q4 Earnings Snapshot

Codexis: Q4 Earnings Snapshot

CDXS : 2.76 (+1.10%)
Codexis: Q3 Earnings Snapshot

Codexis: Q3 Earnings Snapshot

CDXS : 2.76 (+1.10%)
Codexis: Q2 Earnings Snapshot

Codexis: Q2 Earnings Snapshot

CDXS : 2.76 (+1.10%)
Codexis (CDXS) Reports Q1 Loss, Lags Revenue Estimates

Codexis (CDXS) delivered earnings and revenue surprises of -17.24% and 11.34%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

CDXS : 2.76 (+1.10%)
CTMX : 1.7600 (-5.38%)
Codexis: Q1 Earnings Snapshot

Codexis: Q1 Earnings Snapshot

CDXS : 2.76 (+1.10%)
Will Alimera Sciences (ALIM) Report Negative Q1 Earnings? What You Should Know

Alimera Sciences (ALIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ALIM : 3.55 (-0.84%)
CDXS : 2.76 (+1.10%)
Codexis (CDXS) Expected to Beat Earnings Estimates: Should You Buy?

Codexis (CDXS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CDXS : 2.76 (+1.10%)
EDIT : 5.61 (-4.10%)
Codexis (CDXS) Reports Q4 Loss, Tops Revenue Estimates

Codexis (CDXS) delivered earnings and revenue surprises of 17.39% and 4.30%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

CDXS : 2.76 (+1.10%)
PLRX : 12.86 (-3.02%)
Codexis: Q4 Earnings Snapshot

Codexis: Q4 Earnings Snapshot

CDXS : 2.76 (+1.10%)
How Much Upside is Left in Codexis (CDXS)? Wall Street Analysts Think 219%

The consensus price target hints at a 219.4% upside potential for Codexis (CDXS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate...

CDXS : 2.76 (+1.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Codexis is a leading protein engineering company that applies its proprietary CodeEvolver technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and...

See More

Key Turning Points

3rd Resistance Point 2.94
2nd Resistance Point 2.89
1st Resistance Point 2.83
Last Price 2.76
1st Support Level 2.71
2nd Support Level 2.66
3rd Support Level 2.60

See More

52-Week High 4.91
Fibonacci 61.8% 3.59
Fibonacci 50% 3.18
Fibonacci 38.2% 2.77
Last Price 2.76
52-Week Low 1.45

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar